Proficient enough in English, Spanish, and Arabic, Sherif El-Refai took an interest in a therapeutic mission to Tegucigalpa, Honduras, in 2009. Out of 60 volunteers, he was chosen for the 12-member group that represented to speak at the inaugural pharmacy student contingent. Apart from this Sherif El-Refai and his team dispersed school supplies, toys, garments, sustenance, and therapeutic supplies and treated 1,700 patients.
In 2011, Sherif El-Refai finished research for Via Oncology Pathways, a business committed to keeping up confirm based, consistently refreshed calculations for malignant hematology patient and basic oncology introductions. In this position, he dissected renal cell carcinoma and pancreatic adenocarcinoma treatment pathways.
Further in 2012, Sherif El-Refai attempted research at the Center for Pharmacogenomics, in its Department of Pharmacotherapy and Translational Research. There he worked with Julie Johnson to arrange the clinical administration utilization of significant pharmacogenomics progressions that came as a result of a $1.6 million National Institutes of Health grant. Through this examination, he built up a self-sustainable model for the center's clinical pharmacogenomics benefit.
Sherif El-Refai engaged himself by holding a membership to the American Pharmacists Association, the American Society of Health-System Pharmacists, and the North Carolina Association of Pharmacists. He formerly belonged to the Carolina Association of Pharmacy Students.